Saturday, July 11, 2026

pharma · NSCLC

Formycon

Formycon clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Planegg, DE HQ
2012 Founded
178 Employees
EMA registrant Type
Company details
Status
Public
HQ
Planegg, DE
Founded
2012
Employees
178
Programs
2
Drugs
4
Patents
0
Intelligence · Clinical Programs

Formycon projects

1 ClinicalTrials.gov programs sponsored by Formycon.

Formycon has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. FYB206-C3-02

    Formycon AG

    NSCLC

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Formycon have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.